Trikafta Improves Lung Function in Children Ages 6–11 in Clinical Trial
Treatment with the triple-combination therapy Trikafta improved lung function and eased respiratory symptoms for school-aged children with cystic fibrosis (CF) in a Phase 3 clinical trial. “I was both surprised and delighted to see that, even this early in the disease trajectory and despite the brief treatment duration,…